ADD ANI AS A TRUSTED SOURCE
googleads
Menu

      
      Bharat Biotech has submitted Covaxin's Phase III trial data...

Bharat Biotech has submitted Covaxin's Phase III trial data...

New Delhi [India], June 21 (ANI): The Hyderabad-based COVID vaccine manufacturing company Bharat Biotech...


      
      Plea in Delhi HC seeking stay on Phase II/III clinical trial...

Plea in Delhi HC seeking stay on Phase II/III clinical trial...

New Delhi [India], June 3 (ANI): A Fresh application was moved in Delhi High Court on Thursday seeking to stay the...

      
      DCGI waiver likely to bring foreign vaccines like Pfizer,...

DCGI waiver likely to bring foreign vaccines like Pfizer,...

New Delhi [India], June 2 (ANI): The Drugs Controller General of India (DCGI) has done away with specific trials...


      
      Zydus Cadila seeks DCGI approval for clinical trials for...

Zydus Cadila seeks DCGI approval for clinical trials for...

New Delhi [India], May 27 (ANI): Zydus Cadila has sought approval from the Drugs Controller General of India...


      
      DCGI approves Phase 2, 3 clinical trials of COVAXIN on...

DCGI approves Phase 2, 3 clinical trials of COVAXIN on...

New Delhi [India], May 13 (ANI): The Drugs Controller General of India (DCGI) on Thursday approved Phase 2 and 3...


      
      DRDO's anti-COVID 2-DG drug effective against different...

DRDO's anti-COVID 2-DG drug effective against different...

New Delhi [India], May 8 (ANI): The Defence Research and Development Organisation (DRDO)'s new anti-COVID drug,...


      
      DCGI nods anti-COVID drug developed by DRDO for emergency use

DCGI nods anti-COVID drug developed by DRDO for emergency use

New Delhi [India], May 8 (ANI): The Drugs Controller General of India (DCGI) has approved the emergency use of an...

      
      VINS Bioproducts gets DCGI nod to commence clinical trials...

VINS Bioproducts gets DCGI nod to commence clinical trials...

Hyderabad (Telangana) [India], April 26 (ANI): VINS Bioproducts on Monday received approval from the Drugs...

      
      SEC recommends authorisation to Covaxin without 'clinical...

SEC recommends authorisation to Covaxin without 'clinical...

New Delhi [India], March 10 (ANI): The Subject expert committee (SEC) of Drugs Controller General of India (DCGI)...


      
      Dr Reddy's initiates process for emergency use authorisation...

Dr Reddy's initiates process for emergency use authorisation...

Hyderabad (Telangana) [India], Feb 19 (ANI): Dr Reddy's Laboratories said on Friday it has initiated the process...

      
      Serum Institute seeks DCGI nod for clinical trials of...

Serum Institute seeks DCGI nod for clinical trials of...

New Delhi [India], January 30 (ANI): Pharma giant Serum Institute of India (SII), whose Covishield vaccine has...

      
      Sputnik V meets primary endpoint of safety in phase 2...

Sputnik V meets primary endpoint of safety in phase 2...

Hyderabad (Telangana) [India], January 12 (ANI): Dr Reddy's Laboratories has said that independent Data and Safety...
Home About Us Our Products Advertise Contact Us Terms & Condition Privacy Policy

Copyright © aninews.in | All Rights Reserved.